Janus Henderson Group PLC cut its holdings in Innospec Inc. (NASDAQ:IOSP – Free Report) by 11.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 133,272 shares of the specialty chemicals company’s stock after selling 17,579 shares during the quarter. Janus Henderson Group PLC owned 0.54% of Innospec worth $9,732,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in IOSP. Assenagon Asset Management S.A. lifted its position in shares of Innospec by 175.5% during the 1st quarter. Assenagon Asset Management S.A. now owns 490,884 shares of the specialty chemicals company’s stock valued at $35,844,000 after buying an additional 312,680 shares in the last quarter. Western Standard LLC grew its position in shares of Innospec by 894.0% in the fourth quarter. Western Standard LLC now owns 268,367 shares of the specialty chemicals company’s stock valued at $20,541,000 after purchasing an additional 241,367 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Innospec by 71.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 484,968 shares of the specialty chemicals company’s stock worth $37,119,000 after purchasing an additional 202,325 shares in the last quarter. Millennium Management LLC raised its position in shares of Innospec by 8,176.5% during the 1st quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock worth $16,147,000 after purchasing an additional 168,355 shares during the last quarter. Finally, Medina Value Partners LLC raised its position in shares of Innospec by 60.5% during the 4th quarter. Medina Value Partners LLC now owns 378,769 shares of the specialty chemicals company’s stock worth $28,991,000 after purchasing an additional 142,813 shares during the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.
Innospec Stock Performance
IOSP stock opened at $91.96 on Thursday. Innospec Inc. has a one year low of $65.51 and a one year high of $93.34. The firm has a market cap of $2.26 billion, a PE ratio of 18.77, a PEG ratio of 2.39 and a beta of 0.93. The firm’s 50 day moving average price is $83.41 and its 200-day moving average price is $79.56.
Wall Street Analyst Weigh In
IOSP has been the topic of several research analyst reports. Zacks Research upgraded Innospec from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th. Wall Street Zen upgraded Innospec from a “hold” rating to a “buy” rating in a research report on Saturday, July 18th. Finally, Weiss Ratings raised Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 1st. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has an average rating of “Hold”.
Read Our Latest Stock Report on IOSP
About Innospec
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
See Also
- Five stocks we like better than Innospec
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
